Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Polyclonal spread and outbreaks with ESBL positive gentamicin resistant Klebsiella spp. in the region Kennemerland, The Netherlands.

Souverein D, Boers SA, Veenendaal D, Euser SM, Kluytmans J, Den Boer JW.

PLoS One. 2014 Jun 27;9(6):e101212. doi: 10.1371/journal.pone.0101212. eCollection 2014.

2.

[Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].

González Mesa L, Ramos Morí A, Nadal Becerra L, Morffi Figueroa J, Hernández Robledo E, Alvarez AB, Marchena Bequer JJ, González Alemán M, Villain Plous C.

Rev Cubana Med Trop. 2007 Jan-Apr;59(1):52-8. Spanish.

PMID:
23427419
3.

Clonal transmission of ESBL-producing Klebsiella spp. at a university hospital in Brazil.

Minarini LA, Clímaco EC, Guimarães DB, Ferreira JC, Palazzo IC, Martinez R, Darini AL.

Curr Microbiol. 2008 Jun;56(6):587-91. doi: 10.1007/s00284-008-9129-5. Epub 2008 Mar 20.

PMID:
18351418
4.

Extended-spectrum β-lactamase producing Klebsiella spp. in chicken meat and humans: a comparison of typing methods.

Overdevest IT, Heck M, van der Zwaluw K, Huijsdens X, van Santen M, Rijnsburger M, Eustace A, Xu L, Hawkey P, Savelkoul P, Vandenbroucke-Grauls C, Willemsen I, van der Ven J, Verhulst C, Kluytmans JA.

Clin Microbiol Infect. 2014 Mar;20(3):251-5. doi: 10.1111/1469-0691.12277. Epub 2013 Aug 19.

5.
6.
7.

Screening and confirmatory testing for extended spectrum beta-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates.

Hadziyannis E, Tuohy M, Thomas L, Procop GW, Washington JA, Hall GS.

Diagn Microbiol Infect Dis. 2000 Feb;36(2):113-7.

PMID:
10705053
8.

Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?

Damjanova I, Tóth A, Pászti J, Hajbel-Vékony G, Jakab M, Berta J, Milch H, Füzi M.

J Antimicrob Chemother. 2008 Nov;62(5):978-85. doi: 10.1093/jac/dkn287. Epub 2008 Jul 30.

PMID:
18667450
9.

Nosocomial and community infections due to class A extended-spectrum β-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil.

Wollheim C, Guerra IM, Conte VD, Hoffman SP, Schreiner FJ, Delamare AP, Barth AL, Echeverrigaray S, Costa SO.

Braz J Infect Dis. 2011 Mar-Apr;15(2):138-43.

10.

The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark.

Kjerulf A, Hansen DS, Sandvang D, Hansen F, Frimodt-Møller N.

APMIS. 2008 Feb;116(2):118-24. doi: 10.1111/j.1600-0463.2008.00777.x.

PMID:
18321362
12.

Occurrence of extended-spectrum betalactamases (ESBL) in Dutch hospitals.

Stobberingh EE, Arends J, Hoogkamp-Korstanje JA, Goessens WH, Visser MR, Buiting AG, Debets-Ossenkopp YJ, van Ketel RJ, van Ogtrop ML, Sabbe LJ, Voorn GP, Winter HL, van Zeijl JH.

Infection. 1999 Nov-Dec;27(6):348-54.

PMID:
10624595
14.

Molecular and epidemiological analysis of nosocomial carbapenem-resistant Klebsiella spp. using repetitive extragenic palindromic-polymerase chain reaction and matrix-assisted laser desorption/ionization-time of flight.

Treviño M, Navarro D, Barbeito G, García-Riestra C, Crespo C, Regueiro BJ.

Microb Drug Resist. 2011 Sep;17(3):433-42. doi: 10.1089/mdr.2010.0182. Epub 2011 May 13.

PMID:
21568752
15.

Evaluation of MLVA for epidemiological typing and outbreak detection of ESBL-producing Escherichia coli in Sweden.

Helldal L, Karami N, Welinder-Olsson C, Moore ER, Åhren C.

BMC Microbiol. 2017 Jan 6;17(1):8. doi: 10.1186/s12866-016-0922-1.

16.

Next-generation sequencing for typing and detection of resistance genes: performance of a new commercial method during an outbreak of extended-spectrum-beta-lactamase-producing Escherichia coli.

Veenemans J, Overdevest IT, Snelders E, Willemsen I, Hendriks Y, Adesokan A, Doran G, Bruso S, Rolfe A, Pettersson A, Kluytmans JA.

J Clin Microbiol. 2014 Jul;52(7):2454-60. doi: 10.1128/JCM.00313-14. Epub 2014 Apr 30.

17.

High prevalence of ESBL-producing Enterobacteriaceae carriage in Dutch community patients with gastrointestinal complaints.

Reuland EA, Overdevest IT, Al Naiemi N, Kalpoe JS, Rijnsburger MC, Raadsen SA, Ligtenberg-Burgman I, van der Zwaluw KW, Heck M, Savelkoul PH, Kluytmans JA, Vandenbroucke-Grauls CM.

Clin Microbiol Infect. 2013 Jun;19(6):542-9. doi: 10.1111/j.1469-0691.2012.03947.x. Epub 2012 Jul 3.

18.

[Molecular characterization of ESBL-producing Klebsiella pneumoniae isolates from intensive care patients].

Chromá M, Kolár M, Marek O, Koukalová D, Sauer P.

Klin Mikrobiol Infekc Lek. 2007 Oct;13(5):206-12. Slovak.

PMID:
17987570
19.

Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002-2004.

Nyberg SD, Osterblad M, Hakanen AJ, Huovinen P, Jalava J; The Finnish Study Group For Antimicrobial Resistance.

Scand J Infect Dis. 2007;39(5):417-24.

PMID:
17464864
20.

Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.

Hanberger H, Burman LG, Cars O, Erlandsson M, Gill H, Nilsson LE, Nordlinder D, Walther SM; ICU STRAMA Study Group.

Acta Anaesthesiol Scand. 2007 Aug;51(7):937-41.

PMID:
17635399

Supplemental Content

Support Center